BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24966078)

  • 1. [Biological network modelling and precision medicine in oncology].
    Calzone L; Kuperstein I; Cohen D; Grieco L; Bonnet E; Servant N; Hupé P; Zinovyev A; Barillot E
    Bull Cancer; 2014 Jun; 101 Suppl 1():S18-21. PubMed ID: 24966078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Personalized medicine in oncology: from hope to reality].
    Besse B; Soria JC
    Rev Prat; 2012 Feb; 62(2):245-6. PubMed ID: 22408877
    [No Abstract]   [Full Text] [Related]  

  • 4. It is fascinating to see how nowadays more and more knowledge of the molecular biological characteristics of the tumour lead to individualisation with surgery, radiotherapy and systemic treatment for patients with a malignancy. Introduction.
    Bartelink H
    Eur J Cancer; 2011 Sep; 47 Suppl 3():xxxv. PubMed ID: 21944037
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomarkers and oncology: the path forward to a learning health system.
    Yu PP; Hoffman MA; Hayes DF
    Arch Pathol Lab Med; 2015 Apr; 139(4):451-6. PubMed ID: 25152310
    [No Abstract]   [Full Text] [Related]  

  • 6. Personalizing oncology: perspectives and prospects.
    Mendelsohn J
    J Clin Oncol; 2013 May; 31(15):1904-11. PubMed ID: 23589547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments and future perspectives of personalized oncology.
    Grüllich C; von Kalle C
    Onkologie; 2012; 35 Suppl 1():4-7. PubMed ID: 22286581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems medicine: a real approach for future personalized oncology?
    Roukos DH
    Pharmacogenomics; 2010 Mar; 11(3):283-7. PubMed ID: 20235782
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of molecular diagnostics in cancer diagnosis and treatment.
    Ozretić L; Heukamp LC; Odenthal M; Buettner R
    Onkologie; 2012; 35 Suppl 1():8-12. PubMed ID: 22286582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalised medicine in oncology: questions for the next 20 years.
    Blay JY; Lacombe D; Meunier F; Stupp R
    Lancet Oncol; 2012 May; 13(5):448-9. PubMed ID: 22554539
    [No Abstract]   [Full Text] [Related]  

  • 11. Translating genomic discoveries to the clinic in pediatric oncology.
    Glade Bender J; Verma A; Schiffman JD
    Curr Opin Pediatr; 2015 Feb; 27(1):34-43. PubMed ID: 25502895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision oncology: an overview.
    Garraway LA; Verweij J; Ballman KV
    J Clin Oncol; 2013 May; 31(15):1803-5. PubMed ID: 23589545
    [No Abstract]   [Full Text] [Related]  

  • 13. Translational medicine promising personalized therapy in oncology.
    Zeng YX; Zhang XS; Liu Q
    Front Med China; 2010 Dec; 4(4):351-5. PubMed ID: 21107749
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH
    Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical research and human and social sciences at Institut National du Cancer (INCa)].
    Amsellem N
    Med Sci (Paris); 2012 Mar; 28 Spec No 1():6. PubMed ID: 22494649
    [No Abstract]   [Full Text] [Related]  

  • 16. [Desperately seeking targets].
    Jordan B
    Med Sci (Paris); 2015 Feb; 31(2):214-7. PubMed ID: 25744270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics.
    Mousses S; Kiefer J; Von Hoff D; Trent J
    Oncogene; 2008 Dec; 27 Suppl 2():S58-66. PubMed ID: 19956181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Precision oncology and molecular tumor boards].
    Mack E; Horak P; Fröhling S; Neubauer A
    Inn Med (Heidelb); 2024 May; 65(5):462-471. PubMed ID: 38652307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Second-line treatment of metastatic non-small cell lung carcinoma: What are the options today? What are the perspectives for tomorrow?].
    Greillier L; Barlesi F
    Rev Mal Respir; 2012 Jan; 29(1):4-6. PubMed ID: 22240212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.